Traders News Source Issues Stocks on Watch and a New Feature Report

January 25, 2018 -- InvestorsHub NewsWire -- Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a report with no obligation on Curis Stock Price (NASDAQ: CRIS), BIOAMBER INC. (NYSE: BIOA), ProText Mobility, Inc. (OTC: TXTM), Akers Biosciences, Inc. (NASDAQ: AKER) and a comprehensive feature report in one of the hottest sectors in the market.

Curis (NASDAQ: CRIS) Curis recently announced initiation of Phase 1 trial of their drug CA-4948 for the treatment of patients with lymphoma. CA-4948 is a first-in-class, orally available to patients with advanced solid tumors or lymphomas. Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
Get our latest research on a highly-undervalued oil and gas company READ MORE
Copy and paste to your browser may be required to view the report – http://bit.ly/2BoBy1P-Feature-Report

BIOAMBER INC. (NYSE: BIOA) uses sugars instead of fossil fuels and sells competitively priced, sustainable chemicals with strong profit margins and the cleanest environmental footprint in the industry. BIOAMBER INC. is also currently developing a second product platform that uses biotechnology to produce nylon.
ProText Mobility, Inc. (OTC: TXTM) announced that it has signed a binding letter of intent to acquire up to 100% of the ownership in Growprocess, Inc., a blockchain and cannabis compliance advisory firm that has set out to develop a next generation seed-to-sale Blockchain digital ledger platform for the legal cannabis industry. Their Phytofare® catechin complex is now providing inhibiting benefits with metabolic syndrome conditions of obesity, type-2 diabetes and cardiovascular risk.
Get our latest research on a highly-undervalued oil and gas company READ MORE
Copy and paste to your browser may be required to view the report – http://bit.ly/2BoBy1P-Feature-Report

Akers Biosciences, Inc. (NASDAQ: AKER) is a major developer in the health testing and screening products. Tests are designed to provide the same level of accuracy as traditional laboratory testing methods, but at a fraction of the cost and turn-around time. With numerous products now available to physicians this will speed up the diagnoses and plan of care time for each patient.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the subject company in this report to be materially different from the statements made herein.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. Information in this release is fact checked and produced on a best efforts basis. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. The subject Company has not compensated Traders News Source for the creation or dissemination of this report. Traders News Source is the party responsible for issuing the press release and for hosting the full analyst report on Traders News Source website.

NOT FINANCIAL ADVICE
Traders News Source makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Traders News Source is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Traders News Source whatsoever for any direct, indirect or consequential loss arising from the use of this document. Traders News Source expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Traders News Source does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

Source: Traders News Source
Contact: editor@tradersnewssource.com

Akers Biosciences (NASDAQ:AKER)
Historical Stock Chart
From Oct 2024 to Nov 2024